editor@ajptr.com
9409046853
e-ISSN: 2249-3387
logo

American Journal of PharmTech Research

Published

The Degradations Routes of Ramipril and Its Products

Published in April 2015 Issue 2 (Vol. 5, Issue 2, 2015)

The Degradations Routes of Ramipril and Its Products - Issue cover

Abstract

Ramipril is a prodrug of the active metabolite ramiprilat, it inhibits angiotensin-converting enzyme and consequent raise in blood pressure. Its pharmacologic effect aids the treatment of hypertension, congestive heart failure and reduces mortality in post myocardial infarction patients. As for other drugs, Ramipril might degrade upon storage and compromise the quality, efficacy and safety of the product. In order to avoid deterioration, it is important to characterize the degradation products and source of stress (temperature, water content, oxidizers, etc). This review aims to summarize the data concerning the subject and serve as a guide for further studies.

Authors (3)

Guilherme Davi Aschar

View all publications →

Paulo Cesar Pires Rosa

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPTR52006

AJPTR-01-002720

2015-04-01

Article Impact

Views:3,034
Downloads:1,915

How to Cite

Davi, G., & Oliveira & Paulo Cesar Pires Rosa (2015). The Degradations Routes of Ramipril and Its Products. American Journal of PharmTech Research, 5(2), xx-xx. https://ajptr.com/articles/AJPTR52006

Article Actions

Whatsapp